can tirzepatide cause pancreatic cancer Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink breast tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Tirzepatide—Friend or Foe in Diabetic

This discrepancy raised alarm bells and prompted a thorough investigation

Nutritional Optimization Despite reduced appetite, maintaining adequate nutrition is essential: Ensure sufficient caloric intake : Work with a healthcare provider or registered dietitian to establish appropriate caloric goals that support gradual, healthy weight loss without excessive restriction Prioritize protein : During weight loss, aim for approximately 1.0-1.2 grams of protein per kilogram of body weight daily to preserve lean muscle mass (patients with kidney disease should follow their provider's specific recommendations) Focus on nutrient density : Choose foods rich in vitamins, minerals, and complex carbohydrates to support energy levels Eat smaller, frequent meals : This approach may be better tolerated given semaglutide's effect on gastric emptying Hydration and Electrolyte Balance Adequate fluid intake is crucial, particularly if experiencing gastrointestinal side effects

This challenges the common assumption that tablets are automatically less effective than injections

Studies show that semaglutide is a GLP-1 receptor agonist, a medication that helps control blood sugar, slows digestion, and reduces appetite and as a result have significant results for weight loss

I was running, he insisted

This could lead to thrombocytopenia